Literature DB >> 6157445

Effect of interferon on colony formation in culture by blast cell progenitors in acute myeloblastic leukemia.

R Taetle, R N Buick, E A McCulloch.   

Abstract

The effect of purified human fibroblast interferon on primary and secondary colony formation by blast progenitors from the peripheral blood of patients with acute myelogenous leukemia was examined. Interferon inhibited blast progenitors and normal granulocyte/macrophage progenitors (CFU-C) in a dose-dependent manner. The magnitude of this effect on blast progenitors and CFU was similar. Interferon also inhibited secondary plating of blast progenitors (self-renewal). This effect was in marked contrast to the effect of adriamycin, which reduced primary plating efficiency of blast progenitors but did not affect self-renewal. Inhibition of blast progenitor proliferation by interferon was markedly reduced when interferon was added after 24 hr of culture and was absent when added after 72 hr. Inhibition of self-renewal was observed even when interferon was added at 72 hr. We conclude that interferon inhibits both primary proliferation and self-renewal of blast progenitors and that this effect is not due to reduction in the number of primary colonies. These experiments provide an example of how cell culture techniques may be used to test antitumor agents for effects on important cellular events other than general cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157445

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Chronic myelogenous leukemia: an overview.

Authors:  D E Bergsagel
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Interferon alfa-2b in the treatment of chronic granulocytic leukemia.

Authors:  D E Bergsagel; R H Haas; H A Messner
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 3.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML).

Authors:  A Z Rohatiner; F R Balkwill; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  Effect of fibroblast interferon on colony tumor growth of miscellaneous solid human tumors.

Authors:  P Schlag; J Wolfrum; W Schreml; C Herfarth
Journal:  Klin Wochenschr       Date:  1982-12-01

6.  A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion.

Authors:  A Z Rohatiner; F R Balkwill; D B Griffin; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.

Authors:  D E Bergsagel; H Messner
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.